CellType
YC W26 ↗New York City, US · Founded 2025 · 2 employees · 3 known investors
CellType uses AI agents and biological models to automate drug discovery, having identified a novel cancer treatment signal and partnering with major pharmaceutical companies.
Founders & leadership· Y Combinator alumni (W26)
DV
David van Dijkin𝕏Co-Founder & CEO
IV
Ivan VrkicinCo-Founder
Investors · 3
In the news
- Claude's Corner: CellType, Teaching LLMs to Speak Biology | StartupHub.aistartuphub.ai · 2026
- CellType: The Agentic Drug Companyycombinator.com · 2026
- Sundar Pichai announces Google's AI milestone in cancer cureetedge-insights.com · 2025
- Google’s Gemma AI model helps discover new potential cancer therapy pathwayblog.google · 2025
- Google CEO Sundar Pichai Says C2S-Scale 27B Foundation Model Generated 'Novel Hypothesis About Cancer Cellular Behavior'etvbharat.com · 2025
- Google’s AI Cracks a New Cancer Codeyahoo.com · 2025